SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-019933
Filing Date
2020-04-30
Accepted
2020-04-30 06:30:45
Documents
14
Period of Report
2020-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrn-8k_20200430.htm   iXBRL 8-K 39057
2 EX-99.1 amrn-ex991_6.htm EX-99.1 427720
3 GRAPHIC go1tefvgibno000001.jpg GRAPHIC 5429
  Complete submission text file 0001564590-20-019933.txt   642182

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amrn-20200430.xsd EX-101.SCH 5784
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20200430_lab.xml EX-101.LAB 20168
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20200430_pre.xml EX-101.PRE 12069
8 EXTRACTED XBRL INSTANCE DOCUMENT amrn-8k_20200430_htm.xml XML 3778
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 20833027
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences